ALT Archived Articles
Altimmune (NASDAQ:ALT): A Promising Pipette in the Metabolic Disease Arena
Published on March 15, 2025
Altimmune (NASDAQ:ALT): A Differentiated Approach to Addressing Obesity and Metabolic Diseases
Published on November 17, 2024
Altimmune: A Promising Contender in the Obesity and NASH Treatment Landscape
Published on September 24, 2024